CLOSE X
Algo Trading
Home

Blogs

Stock Market Blogs

Upcoming IPOs in 2022: List of latest IPOs in 2022 January 04 2022Latest IPO updates

Visit Count: 1609

Upcoming IPO’s in 2022

The primary markets boomed in 2021 as a result of the liquidity-driven, record-high rise in the secondary markets. In 2022, the initial public offering craze is projected to continue.

In the primary markets, 2021 was a record year, with 65 initial public offerings attracting more over Rs 1.3 lakh crore of funding. Retail investors were given the opportunity to purchase shares in new-age and consumer tech businesses, as well as startups, for the first time. Given their significant position in the consumer market, IPOs from Paytm, Zomato, Policybazaar, Nykaa (FSN E-Commerce Ventures), and Star Health prompted optimism among investors.

In terms of subscriptions, the number of IPOs above Rs 5,000 crore, and premium listings, 2021 was also a record year. Given the abundance of liquidity, it was also a fantastic year globally.

Expectations from 2022

Experts believe that IPOs would reach new highs in the New Year, especially if the government announces the much-anticipated share sale of Life Insurance Corporation (LIC), which is estimated to be ranging from Rs 70,000 to Rs 1 lakh crore.

Adani Wilmar, Go Airlines, ESDS Software, Skanray Technologies, Emcure Pharmaceuticals, Tracxn Technologies, Fusion Micro Finance, MobiKwik, Veeda Clinical, VLCC Health Care, Fincare Small Finance Bank, India 1 Payments, Sterlite Power Transmission, Sterlite Power Transmission, Electronics Mart India, Puranik Builders, Prudent Corporate Advisory Services, Healthium Medtech, ESAF Small Finance Bank are some of the companies that have received approval from the market.

Snapdeal, Bharat FIH, Waaree Energies, eMudhra, Droom Technologies, API Holdings (Pharmeasy), Delhivery, Wellness Forever, OYO, and Lava International are among the companies seeking approval for public offering.

LIC, which is yet to publish its draft red herring prospectus, Go Airlines, MobiKwik, Adani Wilmar, Skanray Technologies, ESDS Software, Tracxn Technologies, VLCC Health Care, Prudent Corporate Advisory Services, and Veeda Clinical may open offers between January and March 2022. IPOs of over Rs 2 lakh crore, which are due in 2022, are in the pipeline.

In 2022, the following companies (with approximate IPO size) are expected to hit the market: LIC (Rs 70,000 crore), Delhivery (Rs 7,460 crore), Ola (Rs 7,300 crore), ), MobiKwik (Rs 1,900 crore), Ixigo (Rs 1,600 crore), NSE (Rs 10,000 crore), NSDL (Rs 1,300 crore), OYO (Rs 8,430 crore), Pharmeasy (Rs 6,250 crore), Bajaj Energy (Rs 5,450 crore), Go Airlines (Rs 3,600 crore) and Adani Wilmar (Rs 4,500 crore) are probably scheduled to hit in 2022.

Go Airlines, MobiKwik, Pharmeasy, Delhivery, and Adani Wilmar are all expected to go public in January, while LIC's offering is expected to go public in March.

COMMENTS
Form
Categories
Blog Enquiry

Prevent Unauthorized Transactions in your demat and trading account --> Update your Mobile Number/Email id with your Depository Participant and Stock Broker. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat/trading account directly from CDSL and Stock Exchanges on the same day.........issued in the interest of investors...

1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

2. Update your Mobile Number & Email Id with your Stock Broker/ Depository Participant and receive OTP directly from Depository on your Email Id and/ or Mobile Number to create pledge.

3. Pay 20% upfront margin of the transaction value to trade in cash market segment.

4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued by NSE vide. Circular No. NSE/INSP/45191 dated: July 31, 2020 and NSE/INSP/45534 and BSE vide Notice No. 20200731-7, dated: July 31, 2020 and 20200831- 45 dated: August 31, 2020 and dated: August 31, 2020 and other guidelines issued from time to time in this regard.

5. Check your Securities/ MF/ Bonds in the Consolidated Account Statement issued by NSDL/ CDSL every month.

6. Risk disclosures RISK DISCLOSURES ON DERIVATIVES:

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html
We believe that an educated investor is a protected investor !!!

"As per the directives of CDSL and esteemed Exchanges, it has been made mandatory for every client to furnish their latest KYC details viz. Valid Mobile No., Email- Id & Income range on or before 31.05.2021 else your Account will be marked as Non Compliant and will be Freezed till the compliance of such requirement."
"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
Dear Investor if you wish to revoke your un-executed eDis mandate, please mail us with ISIN and quantity on dp@indiratrade.com by today EOD."
REGISTRATION NOS:

INDIRA SECURITIES PVT.LTD. (SEBI REG.NO.):NSE TMID: 12866, BSE TMID: 663, CDSL DPID: 17000 SEBI REG. NO.: INZ000188930, MCX TM ID: 56470, NCDEX TM ID: 01277, CDSL REG. NO.: IN-DP-90-2015, CIN : U67120MH1996PTC160201

DISCLAIMER:

"INVESTMENT IN SECURITIES MARKET ARE SUBJECT TO MARKET RISKS, READ ALL THE RELATED DOCUMENTS CAREFULLY BEFORE INVESTING."

INVESTORS GRIEVANCE

Indrendu Joshi. Email: compliance@indiratrade.com. Call : 0731-4797275

Investor grievance complaint : complaint@indiratrade.com

INVESTOR CHARTER